Showing results (141-150 of 436) with videos related to
Sort By:
Pageof 44
Experimental Cell Research|August 9, 2011
The unfolded protein response and its role in intestinal homeostasis and inflammationArthur Kaser, Magdalena B Flak, Michal F Tomczak, et al.Gut|January 22, 2011
Crohn's disease: NOD2, autophagy and ER stress convergeTeresa Fritz, Lukas Niederreiter, Timon Adolph, et al.Nature Reviews. Gastroenterology & Hepatology|July 29, 2022
The metabolic nature of inflammatory bowel diseasesTimon E Adolph, Moritz Meyer, Julian Schwärzler, et al.Trends in Endocrinology and Metabolism: TEM|February 19, 2017
Lipocalin-2: A Master Mediator of Intestinal and Metabolic InflammationAlexander R Moschen, Timon E Adolph, Romana R Gerner, et al.Biochemical and Biophysical Research Communications|July 31, 2007
Knockdown of PgP resensitizes leukemic cells to proteasome inhibitorsHolger Rumpold, Christina Salvador, Anna Maria Wolf, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 20, 2020
Association of the COVID-19 pandemic with Internet Search Volumes: A Google TrendsTM AnalysisMaria Effenberger, Andreas Kronbichler, Jae Il Shin, et al.Gut|September 17, 2020
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individualsAlessandro Mantovani, Graziana Petracca, Giorgia Beatrice, et al.Haematologica|September 8, 2006
The effect of zoledronic acid on the function and differentiation of myeloid cellsAnna Maria Wolf, Holger Rumpold, Herbert Tilg, et al.Gastroenterology|June 16, 2010
Inflammatory bowel disease is a risk factor for recurrent venous thromboembolismGottfried Novacek, Ansgar Weltermann, Anna Sobala, et al.Cell Host & Microbe|April 15, 2016
Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota AlterationsAlexander R Moschen, Romana R Gerner, Jun Wang, et al.Pageof 44